Market Overview: The global market for the treatment of Fabry disease was valued at USD 2,500 million in 2022 and is anticipated to reach USD 5,429.73 million by 2032, demonstrating a robust compound annual growth rate (CAGR) of 9% throughout the forecast period. The surge in Fabry disease prevalence and the adoption of advanced therapies […]
